GlassScriptPhysician profile
Erol Nargileci
NPI 1235469263
$8,191.78
in general payments reported to CMS, 2019-2025
40 companies · $613 in 2025
The $613 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,469 · 2020: $509 · 2021: $357 · 2022: $2,032 · 2023: $1,277 · 2024: $933 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,881.66 | 2019-2023 | Avvigo Guidance System, Watchman Access System |
| Heartflow, INC. | $1,373.89 | 2022 | |
| Abbott Laboratories | $828.83 | 2019-2024 | Cardiomems, Diamondback Coronary, Coroflow |
| Abiomed | $361.90 | 2020-2025 | Impella |
| Medtronic, INC. | $355.54 | 2021-2023 | Micra, Onyx Frontier, Telescope |
| Amgen INC. | $301.18 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $298.67 | 2019-2025 | Brilinta, Farxiga |
| Shockwave Medical, INC | $236.23 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $160.22 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $157.87 | 2019-2025 | |
| Medtronic Vascular, INC. | $149.25 | 2019-2020 | |
| Cordis US Corp. | $144.80 | 2023 | Radial 360 |
| Terumo Medical Corporation | $136.61 | 2019-2023 | Azur Cx Detachable |
| E.R. Squibb & Sons, L.L.C. | $136.38 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.81 | 2024-2025 | Jardiance |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $133.66 | 2025 | Carto 3 |
| Esperion Therapeutics, INC. | $115.19 | 2020-2025 | Nexletol |
| Teleflex LLC | $113.71 | 2020-2023 | Turnpike, Guideliner |
| Ekos Corporation | $113.59 | 2019 | |
| Merck Sharp & Dohme LLC | $107.07 | 2024-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $99.35 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $97.56 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.25 | 2019-2024 | Lifevest |
| Chiesi USA, INC. | $87.11 | 2019-2021 | |
| Cvrx, INC. | $80.51 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $67.17 | 2025 | |
| Alnylam Pharmaceuticals INC. | $63.83 | 2024-2025 | Onpattro |
| Cardiovascular Systems INC. | $55.95 | 2019-2023 | Diamondback Coronary |
| Novo Nordisk INC | $41.95 | 2023 | Ozempic |
| Philips North America LLC | $40.87 | 2023 | |
| W. L. Gore & Associates, INC. | $34.28 | 2022 | |
| Cook Medical LLC | $27.04 | 2019 | |
| Edwards Lifesciences Corporation | $24.80 | 2023 | Hemosphere |
| Acist Medical Systems, INC. | $24.59 | 2019 | |
| Baxter Healthcare | $24.39 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $24.00 | 2021 | |
| Cardiva Medical, INC. | $23.36 | 2025 | Optowire |
| Angiodynamics, INC. | $16.37 | 2023 | Soft-Vu |
| Lantheus Medical Imaging, INC. | $14.18 | 2021 | |
| Scpharmaceuticals INC. | $14.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erol Nargileci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.